Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
4.165
+0.145 (3.61%)
At close: Sep 11, 2026, 4:00 PM EDT
4.150
-0.015 (-0.36%)
After-hours: Sep 11, 2026, 7:57 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $6.8 million as of September 11, 2026. Its market cap has decreased by -31.29% in one year.
Market Cap
6.80M
Enterprise Value
2.12M
1-Year Change
-31.29%
Ranking
Category
Stock Price
$4.17
ChartMarket Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $6.80M, a decrease of -96.55%. That is a compound annual growth rate of -46.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 6.80M | -27.81% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 7.81M |
| Bolt Biotherapeutics | 7.61M |
| Acurx Pharmaceuticals | 7.38M |
| AIM ImmunoTech | 6.75M |
| CollPlant Biotechnologies | 6.62M |
| Lexaria Bioscience | 6.56M |
| Enveric Biosciences | 6.36M |
| Creative Medical Technology Holdings | 6.33M |